Plaintiffs Fourth Amended Petition - Texas State Securities Board
Plaintiffs Fourth Amended Petition - Texas State Securities Board
Plaintiffs Fourth Amended Petition - Texas State Securities Board
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
iii.<br />
iv.<br />
Kiesling Porter has no legal obligation, ability or wherewithal to litigate<br />
any contestable matters that relate to said life insurance policies or the<br />
payment of claims thereon, and<br />
Kiesling, Porter is not required to continue to serve as the escrow agent, or<br />
as the beneficiary of the policies, and it can relinquish its duties by<br />
canceling the Escrow Agreement at any time.<br />
E. Investors are not named as “irrevocable co-beneficiaries” or as any type of<br />
beneficiary with the insurance carriers; but rather, are completely unknown by the<br />
carriers, and are therefore not entitled to receive the death benefits of the life<br />
insurance policies from the issuing insurance carrier when the insured dies.<br />
F. The assets, liabilities or capitalization of Defendant Retirement Value and<br />
Kiesling Porter, or any information that would allow a prospective investor to<br />
assess or verify that Defendant Retirement Value and Kiesling Porter could<br />
continue to operate through the maturity of investments in the RSLIP Program.<br />
G. The identity of and information about the “Policy Financing Entity,” the “Policy<br />
Aggregator,” and persons and entities who perform managerial efforts in regard to<br />
the RSLIP Program.<br />
H. Information relating to the methodology used to track the insured and determine<br />
when he or she dies.<br />
I. True and accurate information regarding the life expectancy estimates.<br />
J. A true and accurate accounting of the actual or anticipated use of investor funds<br />
including, but not limited to, the amount of investor funds that will be used to pay<br />
commissions to sales agents, fees or profits to Retirement Value and its agents,<br />
and the salaries or other payments made to management, the effectuation of<br />
medical reviews to predict a date of death, the use of Kiesling Porter as a<br />
purported “escrow agent” and any other fees or charges associated with the<br />
RSLIP Program. For example, disclosing to investors that 30-40% of investors’<br />
funds were used to pay commissions to sales agents, fees, and profits to<br />
Retirement Value, and its agents in addition to the amount of investor funds used<br />
to acquire the life insurance policies and pay the policy premiums,<br />
K. Defendants Retirement Value routinely instructed Kiesling Porter to use funds<br />
purportedly escrowed to pay the purchase price and premiums for one policy to<br />
pay portions of the purchase price and premiums for other policies.<br />
<strong>State</strong> of <strong>Texas</strong> v. Retirement Value, LLC, et al.<br />
Plaintiff’s <strong>Fourth</strong> <strong>Amended</strong> Verified <strong>Petition</strong> Page 36 of 57